Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
The Effect of Preemptive Oral Pregabalin As an Element of Multimodal Analgesia in Patients Undergoing Laparoscopic Sleeve Gastrectomy. a Randomized, Prospective, Double Blind Study.
Medical University of Warsaw
90 participants
Apr 24, 2023
INTERVENTIONAL
Conditions
Summary
The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability. The participants will be divided into 2 groups: with or without preemptive pregabalin administration.
Eligibility
Inclusion Criteria2
- Sleeve gastrectomy in patients with BMI > 40 or >35 with comorbidities
- Written informed consent
Exclusion Criteria7
- Patient's refusal
- Known allergies to study medication
- Inability to comprehend or participate In pain scoring scale
- Inability to use intravenous patient controlled analgesia
- Changes of operation extent during procedure
- Revisional operations
- End stage organ failure
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Single dose of pregabalin 150mg in a capsule per os 1 hour before start of the operation.
1 capsule containing placebo per os 1 hour before start of the operation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05804591